| Ticker: | ADXN |
| Current Price: | $2.65 |
| % Daily Change: | -11.96% |
| Volume (1,000s): | 5.16 |
| Average Volume (1,000s): | 3.51 |
| Market Cap (M): | $3.26 |
| 1/2/2024 Price: | $6.30 |
| Change Since Inception: | -57.92% |
Addex Therapeutics Ltd
1968 S Coast HWY #1915
Laguna Beach,
CA 92651, USA
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.
Addex was founded in 2002, headquartered in Geneva, Switzerland. and listed on the SIX Swiss Stock Exchange under the trading symbol ADXN since 2007, and on the NASDAQ exchange also under the trading symbol ADXN since 2020.